Article Document Academic Article Information Content Entity Continuant Continuant Journal Article Entity Entity Generically Dependent Continuant 2025-05-10T20:04:28 RDF description of Birth and early developmental screening outcomes associated with cannabis exposure during pregnancy - http://repository.healthpartners.com/individual/document-rn21129 10.1038/s41372-019-0576-6 3 public 28108 Pediatrics Observational Studies Screening Journal of Perinatology 16794 2022-02-21T22:48:57.408-06:00 Adverse Effects Medical Records Systems, Computerized Pregnancy Birth and early developmental screening outcomes associated with cannabis exposure during pregnancy Perinatal Care document-rn21129 Substance Abuse Cohort Studies <p>OBJECTIVE: To compare birth and early developmental screening outcomes for infants with and without in utero cannabis exposures. STUDY DESIGN: Observational cohort of women receiving prenatal care within a large health system, live birth between October 1, 2015 and December 1, 2017, and at least one infant visit. Cannabis exposure was through routine urine toxicology screen. Preterm birth, small for gestational age (SGA) birth, birth defects, and early developmental screening outcomes were assessed from birth and electronic health record data. RESULTS: Of 3435 women, 283 (8.2%) had a positive urine toxicology screen. In utero cannabis exposure was associated with SGA birth, adjusted rate ratio (aRR) 1.69 (95% confidence interval [CI]: 1.22-2.34). Abnormal 12-month developmental screens occurred in 9.1% of infants with in utero cannabis exposure vs. 3.6% of those with negative maternal screens, aRR 1.90 (95% CI: 0.92-3.91). Additional birth outcomes were not associated with in utero cannabis exposure. CONCLUSIONS: Exposure to cannabis during pregnancy may adversely impact fetal growth.<p> 40